Neuropathic Pain Syndromes

Raj's Practical Management of Pain

Volumn , Issue , 2008, Pages 427-443

  Williams, Kayode A ^a   Hurley, Robert W ^a   Lin, Elaina E ^a   Wu, Christopher L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882896507     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032304184-3.50024-8     Document Type: Chapter

References (149)

1. Raja SN, Grabow TS Complex regional pain syndrome I (reflex sympathetic dystrophy). Anesthesiology 2002, 96:1254-1260.
2. Veldman PH, Reynen HM, Arntz IE, et al. Signs and symptoms of reflex sympathetic dystrophy: Prospective study of 829 patients. Lancet 1993, 342:1012-1016.
3. Shefali A, Broatch J, Raja SN Web-based epidemiological survey of complex regional pain syndrome-1 (poster) 2005, The American Society of Anesthesiologists, New Orleans.
4. Allen G, Galer BS, Schwartz L Epidemiology of complex regional pain syndrome: A retrospective chart review of 134 patients. Pain 1999, 80:539-544.
5. Lynch ME Psychological aspects of reflex sympathetic dystrophy: A review of the adult and pediatric literature. Pain 1992, 49:337-347.
6. Kemler MA, de Vet HCW Health-related quality of life in chronic refractory reflex sympathetic dystrophy (complex regional pain syndrome type I). J Pain Symptom Manage 2000, 20:68-76.
7. Janig W Pathophysiology of complex regional pain syndrome. Pain 2005 an updated review 2005, 307-316. IASP Press, Seattle.
8. Janig W, Baron R Complex regional pain syndrome is a disease of the central nervous system. Clin Auton Res 2002, 12:150-164.
9. Mailis-Gagnon A, Giannoylis I, Downar J, et al. Altered central somatosensory processing in chronic pain patients with hysterical anesthesia. Neurology 2003, 60:1501-1507.
10. Maihofner C, Handwerker HO, Neundofer B, et al. Patterns of cortical reorganization in complex regional pain syndrome. Neurology 2003, 61:1707-1715.
11. Maihofner C, Handwerker HO, Neundofer B, et al. Cortical reorganization in during recovery from complex regional pain syndrome. Neurology 2004, 63:693-701.
12. Schwenkreis P, Janssen F, Rommel O, et al. Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand. Neurology 2003, 61:515-519.
13. Woolf CJ, Mannion RJ Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
14. Rommel O, Gehling M, Dertwinkel R, et al. Hemisensory impairment in patients with complex regional pain syndrome. Pain 1999, 80:95-101.
15. Torebjork E, Wahren L, Wallin G, et al. Noradrenalin-evoked pain in neuralgia. Pain 1995, 63:11-20.
16. Ali Z, Raja SN, Wesselmann U, et al. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 2000, 88:161-168.
17. Janig W, Baron R Complex regional pain syndrome: Mystery explained?. Lancet Neurology 2003, 2:687-697.
18. Woolf CJ, Ma QP, Poole S Peripheral cell types contributing to the analgesic action of nerve growth factor in inflammation. J Neurosci 1996, 16:6-23.
19. Stanton-Hicks M, Jänig W, Hassenbusch S, Haddox JD, et al. Reflex sympathetic dystrophy: Changing concepts and taxonomy. Pain 1995, 63:127-133.
20. Reinders M, Geertzen J, Dijkstra PU Complex regional pain syndrome type I: Use of the International Association for the Study of Pain diagnostic criteria defined in 1994. Clin J Pain 2002, 18:207-215.
21. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. Pain 1999, 81:147-154.
22. Baron R, Binder A, Lugwig J, et al. Diagnostic tools and evidence-based treatment of complex regional pain syndrome. Pain 2005 an updated review 2005, 293-306. IASP Press, Seattle.
23. Schurmann M, Gradl G, Andress HJ, et al. Assessment of peripheral sympathetic nervous function for diagnosing early post-traumatic complex regional pain syndrome type I. Pain 1999, 80:149-159.
24. Harden RN, Bruehl S, Galer BS, et al. Complex regional pain syndrome: Are the IASP diagnostic criteria valid and sufficiently comprehensive?. Pain 1999, 83:211-219.
25. Wasner G, Schattschneider J, Baron R Skin temperature side differences-A diagnostic tool for CRPS?. Pain 2002, 98:19-26.
26. Wasner G, Schattschneider J, Heckmann K, et al. Vascular abnormalities in reflex sympathetic dystrophy (CRPS): Mechanism and diagnostic value. Brain 2001, 124:587-599.
27. Gellman H, Keenan MA, Stone L, et al. Reflex sympathetic dystrophy in brain-injured patients. Pain 1992, 51:307-311.
28. Coderre TJ, Xanthos DN, Francis L, et al. Chronic post-ischemia pain (CPIP): A novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain 2004, 112:94-105.
29. Connelly NR, Reuben S, Brull SJ Intravenous regional anesthesia with ketorolac-lidocaine for the management of sympathetically-mediated pain. Yale J Biol Med 1995, 68:95-99.
30. Raja SN, Haythornthwaite JA, Pappagallo, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomised, placebo-controlled trial. Neurology 2002, 59:1015-1021.
31. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain with normal or depressed mood. Neurology 1987, 37:589-596.
32. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005, 116:109-118.
33. Westanmo AD, Gayken J, Haight R Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor. Am J Health Syst Pharm 2005, 62:2481-2490.
34. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005, 115:254-263.
35. van de Vusse AC, Stomp-van den Berg SG, Kessels AH, et al. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1. BMC Neurol 2004, 29:4-13.
36. Becker WJ, Ablett DP, Harris CJ, et al. Long term treatment of intractable reflex sympathetic dystrophy with intrathecal morphine. Can J Neurol Sci 1995, 22:153-159.
37. Perez RS, Zuurmond WW, Bezemer PD, et al. The treatment of complex regional pain syndrome type I with free radical scavengers: A randomized controlled study. Pain 2003, 102:297-307.
38. Hord AH, Rooks MD, Stephens BO, et al. Intravenous regional bretylium and lidocaine for treatment of reflex sympathetic dystrophy: A randomized, double-blind study. Anesth Analg 1992, 74:818-821.
39. Price DD, Long S, Wilsey B, et al. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clin J Pain 1998, 14:216-226.
40. Grabow TS, Tella PK, Raja SN Spinal cord stimulation for complex regional pain syndrome: An evidence-based medicine review of the literature. Clin J Pain 2003, 19:371-383.
41. Johnson RW, Whitton TL Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother 2004, 5:551-559.
42. Opstelten W, van Wijck AJ, Stolker RJ Interventions to prevent postherpetic neuralgia: Cutaneous and percutaneous techniques. Pain 2004, 107:202-206.
43. Johnson RW, Dworkin RH Treatment of herpes zoster and postherpetic neuralgia. BMJ 2003, 326:748-750.
44. Argoff CE, Katz N, Backonja M Treatment of postherpetic neuralgia: A review of therapeutic options. J Pain Symptom Manage 2004, 28:396-411.
45. Jackson JL, Gibbons R, Meyer G, et al. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: A meta-analysis. Arch Intern Med 1997, 157:909-912.
46. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271-2284.
47. Schmader K Herpes zoster in older adults. Clin Infect Dis 2001, 32:1481-1486.
48. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998, 280:1837-1842.
49. Bennett MI, Simpson KH Gabapentin in the treatment of neuropathic pain. Palliat Med 2004, 18:5-11.
50. Maneuf YP, Gonzalez MI, Sutton KS, et al. Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell Mol Life Sci 2003, 60:742-750.
51. Hempenstall K, Nurmikko TJ, Johnson RW Analgesic therapy in postherpetic neuralgia: A quantitative systematic review. PLoS Med 2005, 2:e164.
52. Rice AS, Maton S, Postherpetic Neuralgia Study Group Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001, 94:215-224.
53. Backonja M, Glanzman RL Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003, 25:81-104.
54. Frampton JE, Foster RH Pregabalin: In the treatment of postherpetic neuralgia. Drugs 2005, 65:111-118.
55. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005, 115:254-263.
56. Dworkin RH, Corbin AE, Young JP, et al. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003, 22(60):1274-1283.
57. Gilron I, Max MB Combination pharmacotherapy for neuropathic pain: Current evidence and future directions. Expert Rev Neurother 2005, 5:823-830.
58. Comer AM, Lamb HM Lidocaine patch 5%. Drugs 2000, 59:245-249.
59. Gammaitoni AR, Alvarez NA, Galer BS Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: A review of the literature. J Clin Pharmacol 2003, 43:111-117.
60. Davies PS, Galer BS Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004, 64:937-947.
61. Argoff CE, Galer BS, Jensen MP, et al. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: Assessment with the neuropathic pain scale. Curr Med Res Opin 2004, 20(suppl 2):S21-S28.
62. Katz NP, Gammaitoni AR, Davis MW, et al. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: An effectiveness trial. Pain Med 2002, 3:324-332.
63. Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrollment study. Pain 1999, 80:533-538.
64. Dellemijn P Are opioids effective in relieving neuropathic pain?. Pain 1999, 80:453-462.
65. Benedetti F, Vighetti S, Amanzio M, et al. Dose-response relationship in nociception and neuropathic postoperative pain. Pain 1998, 74:205-211.
66. Wu CL, Tella P, Staats PS, et al. Analgesic effects of intravenous lidocaine and morphine on postamputation pain: A randomized double-blind, active placebo-controlled, crossover trial. Anesthesiology 2002, 96:841-848.
67. Rowbotham MC, Reisner-Keller LA, Fields HL, et al. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991, 41:1024-1028.
68. Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003, 348:1223-1232.
69. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002, 59:1015-1021.
70. Dellemijn PL, Vanneste JA Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997, 349:753-758.
71. Watson CP, Babul N Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998, 50:1837-1841.
72. Rowbotham MC, Reisner LA, Davies PS, et al. Treatment response in antidepressant-naive postherpetic neuralgia patients: Double-blind, randomized trial. J Pain 2005, 6:741-746.
73. Sindrup SH, Jensen TS Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999, 83:389-400.
74. Collins SL, Moore RA, McQuay HJ, et al. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage 2000, 20:449-458.
75. Graff-Radford SB, Shaw LR, et al. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 2000, 16:188-192.
76. Janig W, Levine JD, Michaelis M, et al. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res 1996, 113:161-184.
77. Choi B, Rowbotham MC Effect of adrenergic receptor activation on postherpetic neuralgia pain and sensory disturbances. Pain 1997, 69:55-63.
78. Colding A The effect of regional sympathetic blocks in the treatment of herpes zoster. Acta Anaesthesiol Scand 1969, 13:133-141.
79. Colding A Treatment of pain: organization of a pain clinic: Treatment of acute herpes zoster. Proc R Soc Med 1973, 66:541-543.
80. Winnie AP, Hartwell PW Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of postherpetic neuralgia: Clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993, 18:277-282.
81. Kingery WS A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997, 73:123-139.
82. Hogan QH, Abram SE Neural blockade for diagnosis and prognosis. Anesthesiology 1997, 86:216-241.
83. Yanagida H, Suwa K, Corssen G No prophylactic effect of early sympathetic blockade on postherpetic neuralgia. Anesthesiology 1987, 66:73-76.
84. Tenicela R, Lovasik D, Eaglstein W Treatment of herpes zoster with sympathetic blocks. Clin J Pain 1985, 1:63-67.
85. Dworkin RH, Boon RJ, Griffin DR, et al. Postherpetic neuralgia: Impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998, 178(suppl 1):S76-S80.
86. Perkins FM, Kehlet H Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000, 93:1123-1133.
87. Kissin I Preemptive analgesia. Anesthesiology 2000, 93:1138-1143.
88. Ahn HJ, Lim HK, Lee YB, et al. The effects of famciclovir and epidural block in the treatment of herpes zoster. J Dermatol 2001, 28:208-216.
89. Higa K, Hori K, Harasawa I, et al. High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: Comparison with effects of stellate ganglion block. Reg Anesth Pain Med 1998, 23:25-29.
90. Hwang SM, Kang YC, Lee YB, et al. The effects of epidural blockade on the acute pain in herpes zoster. Arch Dermatol 1999, 135:1359-1364.
91. Watson CP, Deck JH, Morshead C, et al. Postherpetic neuralgia: Further postmortem studies of cases with and without pain. Pain 1991, 44:105-117.
92. Kikuchi A, Kotani N, Sato T, et al. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999, 24:287-293.
93. Kotani N, Kushikata T, Hashimoto H, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000, 343:1514-1519.
94. Cunha FQ, Lorenzetti BB, Poole S, et al. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 1991, 104:765-767.
95. Nelson DA Intraspinal therapy using methylprednisolone acetate: Twenty-three years of clinical controversy. Spine 1993, 18:278-286.
96. Wilkinson HA Intrathecal Depo-Medrol: A literature review. Clin J Pain 1992, 8:49-56.
97. Krames E Implantable devices for pain control: Spinal cord stimulation and intrathecal therapies. Best Pract Res Clin Anaesthesiol 2002, 16:619-649.
98. Harke H, Gretenkort P, Ladleif HU, et al. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg 2002, 94:694-700.
99. Turner JA, Loeser JD, Deyo RA, et al. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: A systematic review of effectiveness and complications. Pain 2004, 108:137-147.
100. Boulton AJ, Viink AI, Arezzo JC, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005, 28:956-962.
101. Rathur HM, Boulton AJ Recent advances in the diagnosis and management of diabetic neuropathy. J Bone Joint Surg Br 2005, 87:1605-1610.
102. Gooch C, Podwall D The diabetic neuropathies. Neurologist 2004, 10:311-322.
103. Kelkar P Diabetic neuropathy. Semin Neurol 2005, 25:168-173.
104. Aring AM, Jones DE, Falko JM Evaluation and prevention of diabetic neuropathy. Am Fam Physician 2005, 71:2123-2128.
105. Sinnreich M, Taylor BV, Dyck PJ Diabetic neuropathies: Classification, clinical features, and pathophysiological basis. Neurologist 2005, 11:63-79.
106. Rathur HM, Boulton AJ Recent advances in the diagnosis and management of diabetic neuropathy. J Bone Joint Surg Br 2005, 87:1605-1610.
107. Wiffen PJ, McQuay HJ, Edwards JE, et al. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005, (3). CD005452.
108. Mellegers MA, Furlan AD, Mailis A Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin J Pain 2001, 17:284-295.
109. Lesser H, Sharma U, LaMoreaux L, et al. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 2004, 63:2104-2110.
110. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005, 115:254-263.
111. Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 2005, 6:253-260.
112. Frampton JE, Scott LJ Pregabalin: In the treatment of painful diabetic peripheral neuropathy. Drugs 2004, 64:2813-2820.
113. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334.
114. Saarto T, Wiffen PJ Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005, (3). CD005454.
115. Collins SL, Moore RA, McQuay HJ, et al. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage 2000, 20:449-458.
116. Adriaensen H, Plaghki L, Mathieu C, et al. Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies. Diabetes Metab Res Rev 2005, 21:231-240.
117. Kastrup J, Petersen P, Dejgard A, et al. Intravenous lidocaine infusion-A new treatment of chronic painful diabetic neuropathy?. Pain 1987, 28:69-75.
118. Stracke H, Meyer UE, Schumacher HE, et al. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 1992, 15:1550-1555.
119. Wright JM, Oki JC, Graves L Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharmacother 1997, 31:29-34.
120. Oskarsson P, Ljunggren JG, Lins PE Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group. Diabetes Care 1997, 20:1594-1597.
121. Barbano RL, Herrmann DN, Hart-Gouleau S, et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004, 61:914-918.
122. Criner TM, Perdun CS Dextromethorphan and diabetic neuropathy. Ann Pharmacother 1999, 33:1221-1223.
123. Nelson KA, Park KM, Robinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997, 48:1212-1218.
124. Sang CN, Booher S, Gilron I, et al. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: Efficacy and dose-response trials. Anesthesiology 2002, 96:1053-1061.
125. Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003, 105:71-78.
126. Gimbel JS, Richards P, Portenoy RK Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 2003, 60:927-934.
127. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A meta-analysis. Diabet Med 2004, 21:114-121.
128. Airey M, Bennett C, Nicolucci A, et al. Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy. Cochrane Database Syst Rev 2000, (2). CD002182.
129. Verma A Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 2001, 61:8-13.
130. Schifitto G, McDermott MP, McArthur JC, et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002, 5812:1764-1768.
131. Keswani SC, Pardo CA, Cherry CL, et al. HIV-associated sensory neuropathies. AIDS 2002, 1616:2105-2117.
132. Luciano CA, Pardo CA, McArthur JC Recent developments in the HIV neuropathies. Curr Opin Neurol 2003, 163:403-409.
133. McCarthy BG, Hsieh ST, Stocks A, et al. Cutaneous innervation in sensory neuropathies: Evaluation by skin biopsy. Neurology 1995, 4510:1848-1855.
134. Polydefkis M, Yiannoutsos CT, Cohen BA, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002, 581:115-119.
135. Bradley WG, Shapshak P, Delgado S, et al. Morphometric analysis of the peripheral neuropathy of AIDS. Muscle Nerve 1998, 219:1188-1195.
136. Herzberg U, Sagen J Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol 2001, 1161:29-39.
137. Oh SB, Tran PB, Gillard SE, et al. Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 2001, 2114:5027-5035.
138. Berger AR, Arezzo JC, Schaumburg HH, et al. 2′,3′-dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients. Neurology 1993, 432:358-362.
139. Moore RD, Wong WM, Keruly JC, et al. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 2000, 143:273-278.
140. Kieburtz K, Simpson D, Yiannoutsos C, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology 1998, 516:1682-1688.
141. Paice JA, Ferrans CE, Lashley FR, et al. Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage 2000, 191:45-52.
142. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1998, 28018:1590-1595.
143. Simpson DM, Dorfman D, Olney RK, et al. Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group. Neurology 1996, 475:1254-1259.
144. McArthur JC, Yiannoutsos C, Simpson DM, et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 2000, 545:1080-1088.
145. Simpson DM, Olney R, McArthur JC, et al. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 2000, 5411:2115-2119.
146. Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: A placebo-controlled trial. Neurology 2003, 609:1508-1514.
147. La Spina I, Porazzi D, Maggiolo F, et al. Gabapentin in painful HIV-related neuropathy: A report of 19 patients, preliminary observations. Eur J Neurol 2001, 81:71-75.
148. Newshan G HIV neuropathy treated with gabapentin. Aids 1998, 122:219-221.
149. Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 2004, 25110:1260-1266.